Notoriously hard to treat, pancreatic and colorectal cancers each have high recurrence rates in the years following treatment.
A new ‘off-the-shelf’ vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these…
Notoriously hard to treat, pancreatic and colorectal cancers each have high recurrence rates in the years following treatment.
A new ‘off-the-shelf’ vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these…